191 related articles for article (PubMed ID: 21898484)
1. Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma.
Noda T; Shimoda M; Ortiz V; Sirica AE; Wands JR
Hepatology; 2012 Jan; 55(1):86-97. PubMed ID: 21898484
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells.
Panya A; Thepmalee C; Sawasdee N; Sujjitjoon J; Phanthaphol N; Junking M; Wongkham S; Yenchitsomanus PT
Cancer Immunol Immunother; 2018 Oct; 67(10):1579-1588. PubMed ID: 30056600
[TBL] [Abstract][Full Text] [Related]
3. [Immune response of dendritic cells acquiring antigens from apoptotic cholangiocarcinoma cells induced by mitomycin].
Wu G; Han BL; Pei XT
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):149-52. PubMed ID: 12681060
[TBL] [Abstract][Full Text] [Related]
4. Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.
Shimoda M; Tomimaru Y; Charpentier KP; Safran H; Carlson RI; Wands J
J Hepatol; 2012 May; 56(5):1129-1135. PubMed ID: 22245894
[TBL] [Abstract][Full Text] [Related]
5. Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns.
Jiraviriyakul A; Songjang W; Kaewthet P; Tanawatkitichai P; Bayan P; Pongcharoen S
World J Gastroenterol; 2019 Aug; 25(29):3941-3955. PubMed ID: 31413529
[TBL] [Abstract][Full Text] [Related]
6. Suppression of TGF-β and IL-10 receptors on self-differentiated dendritic cells by short-hairpin RNAs enhanced activation of effector T-cells against cholangiocarcinoma cells.
Thepmalee C; Panya A; Sujjitjoon J; Sawasdee N; Poungvarin N; Junking M; Yenchitsomanus PT
Hum Vaccin Immunother; 2020 Oct; 16(10):2318-2327. PubMed ID: 31976810
[TBL] [Abstract][Full Text] [Related]
7. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
[TBL] [Abstract][Full Text] [Related]
8. Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
Nagaoka K; Ogawa K; Ji C; Cao KY; Bai X; Mulla J; Cheng Z; Wands JR; Huang CK
Dig Dis Sci; 2021 Apr; 66(4):1080-1089. PubMed ID: 32445050
[TBL] [Abstract][Full Text] [Related]
9. Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma.
Shimizu K; Kotera Y; Aruga A; Takeshita N; Takasaki K; Yamamoto M
J Hepatobiliary Pancreat Sci; 2012 Mar; 19(2):171-8. PubMed ID: 21874278
[TBL] [Abstract][Full Text] [Related]
10. A novel "patient-like" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines.
Sirica AE; Zhang Z; Lai GH; Asano T; Shen XN; Ward DJ; Mahatme A; Dewitt JL
Hepatology; 2008 Apr; 47(4):1178-90. PubMed ID: 18081149
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
Specht JM; Wang G; Do MT; Lam JS; Royal RE; Reeves ME; Rosenberg SA; Hwu P
J Exp Med; 1997 Oct; 186(8):1213-21. PubMed ID: 9334360
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.
Hinkel A; Tso CL; Gitlitz BJ; Neagos N; Schmid I; Paik SH; deKernion J; Figlin R; Belldegrun A
J Immunother; 2000 Jan; 23(1):83-93. PubMed ID: 10687141
[TBL] [Abstract][Full Text] [Related]
13. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures.
Brasel K; De Smedt T; Smith JL; Maliszewski CR
Blood; 2000 Nov; 96(9):3029-39. PubMed ID: 11049981
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression profiling of cultured neu-transformed versus spontaneously-transformed rat cholangiocytes and of corresponding cholangiocarcinomas.
Dumur CI; Campbell DJ; DeWitt JL; Oyesanya RA; Sirica AE
Exp Mol Pathol; 2010 Dec; 89(3):227-35. PubMed ID: 20816680
[TBL] [Abstract][Full Text] [Related]
15. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells.
Thepmalee C; Panya A; Junking M; Chieochansin T; Yenchitsomanus PT
Hum Vaccin Immunother; 2018 Jun; 14(6):1423-1431. PubMed ID: 29420117
[TBL] [Abstract][Full Text] [Related]
17. Human cytokine-induced killer cells specifically infiltrated and retarded the growth of the inoculated human cholangiocarcinoma cells in SCID mice.
Wongkajornsilp A; Somchitprasert T; Butraporn R; Wamanuttajinda V; Kasetsinsombat K; Huabprasert S; Maneechotesuwan K; Hongeng S
Cancer Invest; 2009 Feb; 27(2):140-8. PubMed ID: 19235585
[TBL] [Abstract][Full Text] [Related]
18. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.
Tomimaru Y; Mishra S; Safran H; Charpentier KP; Martin W; De Groot AS; Gregory SH; Wands JR
Vaccine; 2015 Mar; 33(10):1256-66. PubMed ID: 25629522
[TBL] [Abstract][Full Text] [Related]
19. Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery.
Koya RC; Kasahara N; Favaro PM; Lau R; Ta HQ; Weber JS; Stripecke R
J Immunother; 2003; 26(5):451-60. PubMed ID: 12973034
[TBL] [Abstract][Full Text] [Related]
20. Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.
Sadeghlar F; Vogt A; Mohr RU; Mahn R; van Beekum K; Kornek M; Weismüller TJ; Branchi V; Matthaei H; Toma M; Schmidt-Wolf IGH; Kalff JC; Strassburg CP; González-Carmona MA
Cancer Immunol Immunother; 2021 May; 70(5):1451-1464. PubMed ID: 33180184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
